BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34513365)

  • 1. Incidence of Secondary Hemophagocytic Lymphohistiocytosis in Critically-Ill COVID-19 Patients.
    Allen J; McCambridge MM; Kincaid H; Kalter JA
    Cureus; 2021 Jul; 13(7):e16735. PubMed ID: 34513365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
    Yang K; Xing MY; Jiang LY; Cai YP; Yang LL; Xie NN; Chen J; Wang WX; Wang L; Zhu JL; Zhang DY; Ruan QR; Song JX
    Curr Med Sci; 2021 Feb; 41(1):39-45. PubMed ID: 33582903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and
    Gautam S; Sharma G; Singla S; Garg S
    Front Med (Lausanne); 2022; 9():835421. PubMed ID: 35783658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
    Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
    Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic Lymphohistiocytosis in a Patient With Acute Respiratory Distress Syndrome Secondary to SARS-CoV-2 Infection.
    Greco GF; Spreafico F; Di Costanzo D; Pecoriello A; Garuti M; Inglese F; Cervi G; De Donno G; Beccaria M
    J Med Cases; 2020 Oct; 11(10):327-329. PubMed ID: 34434340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Hemophagocytic Lymphohistiocytosis in Post-COVID-19 Patients: A Report of Two Cases.
    Kalita P; Laishram D; Dey B; Mishra J; Barman B; Barman H
    Cureus; 2021 Aug; 13(8):e17328. PubMed ID: 34557370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
    Alfaro-Murillo A; Lazo-Paéz G
    Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
    Alunno A; Carubbi F; Rodríguez-Carrio J
    RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
    Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
    Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
    Chen J; Wang X; He P; Li Y; Si M; Fan Z; Chang X; Xie Q; Jiao X
    J Med Virol; 2016 Mar; 88(3):541-9. PubMed ID: 26287378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic Lymphohistiocytosis in a PICU of a Developing Economy: Clinical Profile, Intensive Care Needs, Outcome, and Predictors of Mortality.
    Parajuli B; Angurana SK; Awasthi P; Nallasamy K; Baranwal A; Bansal A; Bansal D; Rawat A; Varma N; Jayashree M
    Pediatr Crit Care Med; 2021 Jan; 22(1):e44-e57. PubMed ID: 33031348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophagocytic Syndrome and COVID-19: A Comprehensive Review.
    Fadlallah MM; Salman SM; Fadlallah MM; Rahal H
    Cureus; 2023 Mar; 15(3):e36140. PubMed ID: 37065291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An elevated HScore is associated with poor clinical outcomes in COVID-19.
    Benavente R; Peña C; Cid A; Cabello N; Bustamante P; Álvarez M; Henríquez E; Soto A; Rubilar E
    Rev Med Chil; 2023 Feb; 151(1):15-22. PubMed ID: 37906742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
    Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
    Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of secondary hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome].
    Wang MM; Qiu HX; Wang JJ; Gao X; Duan LM; Tian T; Cheng WY; Liu LL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):502-506. PubMed ID: 31340624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.